Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
empower glp-1 The Compounding Pharmacy Case Just Got a Quiet but Powerful Update No Synthetic Precursors The U.S. Food and Quantity:6 Months
The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications.
This highlights the importance of M&A for these emerging therapeutics in an investment thesis, as such trials are much more feasible for large pharma companies than for biotech startups
No Synthetic Precursors
Quantity:6 Months
“This sounds corny, but it gave me hope.”
